Literature DB >> 2810338

Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations.

E Bakker1, H Veenema, J T Den Dunnen, C van Broeckhoven, P M Grootscholten, E J Bonten, G J van Ommen, P L Pearson.   

Abstract

In 288 Dutch and Belgian Duchenne and Becker muscular dystrophy families, the parental origin of 41 new deletion or duplication mutations was determined. Twenty seven of the new mutations occurred in the maternal X chromosome and nine in the grandmaternal and five in the grandpaternal X chromosome. The grandparental data are compatible with equal mutation rates for DMD in male and female X chromosomes. New mutations were defined by their presence in one or more progeny and absence in the lymphocytes of the mother or the grandparents. In one family a fraction of the maternal lymphocytes was found to carry the mutation, suggesting somatic mosaicism. In six cases out of 41, the mutation was transmitted more than once by a parent in whom the mutation was absent in lymphocytes, suggesting gonadal mosaicism as the explanation for the multiple transmission. Using our data for the recurrence of the mutations among the total of at risk haplotypes transmitted, we arrive at a recurrence risk of 14% for the at risk haplotype. The observation of this high risk of germinal mosaicism is crucially important for all physicians counselling females in DMD families. Recently, germinal mosaicism has been observed also in a number of other X linked and autosomal disorders. The implications and appropriate diagnostic precautions are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2810338      PMCID: PMC1015693          DOI: 10.1136/jmg.26.9.553

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  21 in total

1.  Preferential deletion of exons in Duchenne and Becker muscular dystrophies.

Authors:  S M Forrest; G S Cross; A Speer; D Gardner-Medwin; J Burn; K E Davies
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

2.  Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen.

Authors:  P H Byers; P Tsipouras; J F Bonadio; B J Starman; R C Schwartz
Journal:  Am J Hum Genet       Date:  1988-02       Impact factor: 11.025

3.  Germinal mosaicism in Duchenne muscular dystrophy.

Authors:  S Wood; B C McGillivray
Journal:  Hum Genet       Date:  1988-03       Impact factor: 4.132

4.  A somatic mosaic for haemophilia A detected at the DNA level.

Authors:  M Higuchi; L Kochhan; K Olek
Journal:  Mol Biol Med       Date:  1988-02

5.  Germline mosaicism and Duchenne muscular dystrophy mutations.

Authors:  E Bakker; C Van Broeckhoven; E J Bonten; M J van de Vooren; H Veenema; W Van Hul; G J Van Ommen; A Vandenberghe; P L Pearson
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

6.  A partial deletion of the muscular dystrophy gene transmitted twice by an unaffected male.

Authors:  B T Darras; U Francke
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

7.  Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels.

Authors:  J T den Dunnen; E Bakker; E G Breteler; P L Pearson; G J van Ommen
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

8.  Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs.

Authors:  E Bakker; M H Hofker; N Goor; J L Mandel; K Wrogemann; K E Davies; L M Kunkel; H F Willard; W A Fenton; L Sandkuyl
Journal:  Lancet       Date:  1985-03-23       Impact factor: 79.321

9.  Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy.

Authors:  S M Forrest; T J Smith; G S Cross; A P Read; N S Thomas; R C Mountford; P S Harper; R T Geirsson; K E Davies
Journal:  Lancet       Date:  1987-12-05       Impact factor: 79.321

10.  Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA.

Authors:  B T Darras; M Koenig; L M Kunkel; U Francke
Journal:  Am J Med Genet       Date:  1988-03
View more
  58 in total

1.  A dominant mutation in the COL1A1 gene that substitutes glycine for valine causes recurrent lethal osteogenesis imperfecta.

Authors:  J Bonaventure; L Cohen-Solal; C Lasselin; P Maroteaux
Journal:  Hum Genet       Date:  1992-08       Impact factor: 4.132

2.  Substitution of aspartate for glycine 1018 in the type III procollagen (COL3A1) gene causes type IV Ehlers-Danlos syndrome: the mutated allele is present in most blood leukocytes of the asymptomatic and mosaic mother.

Authors:  S Kontusaari; G Tromp; H Kuivaniemi; C Stolle; F M Pope; D J Prockop
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

3.  Estimate of germinal mosaicism in Duchenne muscular dystrophy.

Authors:  M R Passos-Bueno; M A Lima; M Zatz
Journal:  J Med Genet       Date:  1990-11       Impact factor: 6.318

4.  Theoretical considerations on germline mosaicism in Duchenne muscular dystrophy.

Authors:  T Grimm; B Müller; C R Müller; M Janka
Journal:  J Med Genet       Date:  1990-11       Impact factor: 6.318

5.  Replacement of arginine 773 by cysteine or histidine in the human androgen receptor causes complete androgen insensitivity with different receptor phenotypes.

Authors:  L Prior; S Bordet; M A Trifiro; A Mhatre; M Kaufman; L Pinsky; K Wrogeman; D D Belsham; F Pereira; C Greenberg
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

6.  Sex ratio of the mutation frequencies in haemophilia A: coagulation assays and RFLP analysis.

Authors:  A H Bröcker-Vriends; F R Rosendaal; J C van Houwelingen; E Bakker; G J van Ommen; J J van de Kamp; E Briët
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

7.  Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophy.

Authors:  Peter J Taylor; Sarah Maroulis; Glenda L Mullan; Robyn L Pedersen; Aurora Baumli; George Elakis; Sara Piras; Corrina Walsh; Benito Prósper-Gutiérrez; Fernando De La Puente-Alonso; Christopher G Bell; David R Mowat; Heather M Johnston; Michael F Buckley
Journal:  J Med Genet       Date:  2007-01-26       Impact factor: 6.318

8.  Germinal "mosaicism"--germline mutation or chimerism?

Authors:  R Witkowski
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

9.  Inversions in the factor VIII gene: improvement of carrier detection and prenatal diagnosis in Dutch haemophilia A families.

Authors:  P P Deutz-Terlouw; M Losekoot; R Olmer; W C Pieneman; S de Vries-v d Weerd; E Briët; E Bakker
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

10.  Somatic mosaicism in a patient with neurofibromatosis type 1.

Authors:  S D Colman; S A Rasmussen; V T Ho; C R Abernathy; M R Wallace
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.